Efficacy and Safety of MK-1293 Insulin Glargine Compared with Originator Insulin Glargine (Lantus) in Type 2 Diabetes (T2D)

Volume 2, Issue 13, Part 3.

Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Marc Rendell from Creighton University School of Medicine about the study: Efficacy and Safety of MK-1293 Insulin Glargine Compared Along with Originator Insulin Glargine (Lantus) in Type 2 Diabetes, presented at the June 2016 American Diabetes Association Scientific Session.

A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care

Volume 2, Issue 13, Part 2.

Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Jeffrey I. Mechanick from the Icahn School of Medicine at Mt. Sinai about his presentation: A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care, presented at the May 2016 AACE Annual Scientific and Clinical Congress.

Inpatient Glycemic Management: From the Bedside to the Cloud

Volume 2, Issue 13, Part 1.

Nestoras Mathioudakis, MD, MD from Johns Hopkins interviews Dr. Sethu Reddy from Cleveland Clinic about the seminar: Inpatient Glycemic Management: From Bedside to the Cloud presented at the May 2016 AACE Annual Scientific and Clinical Congress.

New Insights into Lifestyle Modification

Volume 1, Issue 4.

Ellen M. Mowry, MD, MCR covers the important topic of New Insights into Lifestyle Modification in the format of case-study scenarios for the clinical practice.

To read a companion newsletter click here.